Latest News LIVE Updates: Over 21% Of India's Population May Have Had COVID-19, Shows Sero Survey

Sarkarinaukarialerts

Letest job update

NDTV Coronavirus

Latest News LIVE Updates: Over 21% Of India’s Population May Have Had COVID-19, Shows Sero Survey

The demise depend elevated to 1,54,703 with 107 each day new fatalities, the information confirmed. (File)

New Delhi:

Over 21 per cent of the population, aged 10 years and above, confirmed proof of previous publicity to COVID-19 within the ICMR’s newest nationwide serosurvey, the federal government stated on Thursday, noting that a big proportion of persons are nonetheless susceptible to the an infection.

The Indian Council of Medical Analysis (ICMR) third nationwide serosurvey was performed between December 7 final yr and January 8.

Presenting the findings of the survey, ICMR Director Basic Dr Balram Bhargava stated 21.4 per cent of the 28,589 individuals, aged 18 years and above, surveyed throughout the interval confirmed proof of previous publicity to the coronavirus an infection. Whereas 25.3 per cent of youngsters aged 10 to 17 years from the identical variety of surveyed inhabitants have had the illness, he stated.

India’s COVID-19 tally of instances rose to 1,07,90,183 with 12,899 new infections being reported in a day, whereas the recoveries surged to 1,04,80,455, in response to the Union Well being Ministry information up to date on Thursday.

The demise depend elevated to 1,54,703 with 107 each day new fatalities, the information confirmed.

The quantity of people that have recuperated from the illness surged to 1,04,80,455 pushing the nationwide COVID-19 restoration price of 97.13 per cent, whereas the COVID-19 case fatality price stands at 1.43 per cent. The entire COVID-19 energetic instances remained under 2 lakh.

Listed below are the Newest Information Stay Updates:

Johnson & Johnson Requests Emergency Authorisation For Covid Vaccine

Prescribed drugs big Johnson & Johnson on Thursday submitted an utility for emergency authorization of its Covid-19 vaccine with US well being authorities, the corporate stated in a press release.

The method might take a number of weeks, however on the finish of it the vaccine could be the third licensed in the US, after these of Pfizer-BioNTech and Moderna. 

J&J subsidiary Janssen Biotech “has submitted an utility to the US Meals and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate,” the assertion learn.

The brand new vaccine is extremely anticipated as a result of it has two large logistical benefits: it may be saved at fridge temperatures moderately than in particular freezers, considerably easing distribution; and it requires only one dose.